Biomarkers of Neurodegeneration and Precision Therapy in Retinal Disease
Vision-threatening retinal diseases affect millions of people worldwide, representing an important public health issue (high social cost) for both technologically advanced and new-industrialized countries. Overall RD group comprises the retinitis pigmentosa, the age-related macular degeneration (AMD...
Saved in:
Main Authors: | Alessandra Micera (Author), Bijorn Omar Balzamino (Author), Antonio Di Zazzo (Author), Lucia Dinice (Author), Stefano Bonini (Author), Marco Coassin (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dupilumab‐associated ocular surface disease or atopic keratoconjunctivitis not improved by dupilumab? Upadacitinib may clarify the dilemma: A case report
by: Marco Galluzzo, et al.
Published: (2024) -
Neurodegeneration and Neuroprotection in Retinal Disease
Published: (2020) -
Editorial: Chronic Inflammation and Neurodegeneration in Retinal Disease
by: Francesco Petrillo, et al.
Published: (2021) -
Editorial: Chronic Inflammation and Neurodegeneration in Retinal Disease, Volume II
by: Claudio Bucolo, et al.
Published: (2022) -
Non-Apoptotic Programmed Cell Death as Targets for Diabetic Retinal Neurodegeneration
by: Yingjia Lin, et al.
Published: (2024)